Loratadine oral compound medication composition

A technology of loratadine and desloratadine, which is applied to the pharmaceutical composition for oral administration, and the sustained-release part of the central antitussive drug, can solve the problem of insufficient pharmacokinetic characteristics of treatment and can not meet the needs of patients with frequent coughs. And other issues
CN101015519AInactive Publication Date: 2007-08-15CHONGQING PHARMA RES INST

Patent Information

Authority / Receiving Office
CN Β· China
Patent Type
Applications(China)
Current Assignee / Owner
CHONGQING PHARMA RES INST
Publication Date
2007-08-15
Estimated Expiration
Not applicable Β· inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

This invention relates to an orally adminstered compound Chinese medicinal composition of loratadine for treating cough. The composition comprises quick-release part containing loratadine and slow-release part containing centrum antitussive drug, wherein the centrum antitussive drug is preferably dextromethorphan. The invention maintains the quick and long lasting action of loratadine or desloratadine, overcomes the quick releasing and short action on relieving cough of dextromethorphan, slow releases dextromethorphan, and maintains the drug effect to arrive the purpose of relieving cough for a long time.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to a pharmaceutical composition for oral administration for treating cough, which contains an effective amount of loratadine or desloratadine immediate-release part, and an effective amount of central antitussive Sustained release part, and pharmaceutical excipients. The composition is administered once a day to treat cough and has a long-term effect. Background technique

[0002] Cough is a common symptom of respiratory disease. In recent years, due to the increasingly serious air pollution on the earth, the deterioration of the living environment of human beings, the destruction of the human body's immune function, the incidence of respiratory diseases has been increasing year by year, as evidenced by the prevalence of atypical pneumonia. Statistics show that in the United States, cough is the second largest number of respiratory outpatient visits. Accordi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More